Evidence map›Paper›PMID 40351468›Full record

ReviewFrontiers in medicine2025

Clinical applications, advances, and future directions in hysterosalpingography.

Ting Wang, Tiantian Dong, Fang Nie

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ting Wang *Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, China.
Tiantian Dong *Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, China.
Fang NieUltrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the incidence of infertility has been on the rise, and accurately evaluating the tubal status is of great significance in the diagnostic work-up of infertile women. HyCoSy has a certain proportion of false positives and false negatives in the evaluation of fallopian tube patency. The new third-generation drug-or gene-loaded microbubble contrast agents will largely achieve the dual purpose of diagnosis and treatment in clinical application, especially in transvaginal four-dimensional hysterosalpingo-contrast sonography (TVS 4D-HyCoSy), which has significant clinical value in assessing tubal patency and perifallopian tube adhesions. This study mainly discusses the selection of current diagnostic methods for tubal infertility, the technical challenges, and suggestions for ultrasonic diagnosis and postoperative treatment.

Indexed as

contrast-enhanced ultrasoundfallopian tube patencyhysterosalpingographyinfertilitytransvaginal hydrolaparoscopy

Identifiers

PMID40351468
PMCPMC12061678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.